
Healthcare professionals who have inappropriate financial links with pharma companies will face prosecution and up to 10 years in jail, …

As diabetes patients increase in numbers the cost of treating the disease in England has increased to more than £800 …

Plans to include a price tag on prescription medicines in England worth more than £20 have been dismissed as a …

NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …

The Conservative Government has confirmed the NHS will receive £10 billion in funding by 2020 in the Chancellor’s budget announcement.The …

The number of drugs issued in England continues to soar, according to the latest NHS figures which show prescribing in …
NHS drugs costing more than £20 will, from next year, have the price and the words “funded by the UK …
A NICE appraisal committee has asked for more information on a treatment for chronic dry eye syndrome, after failing to …

In recent months the focus on the need to develop new drugs and fund new treatments for rare diseases has …

NHS England has laid out digital technology plans that it says will completely transform services and improve health outcomes using …

The chairman of the NHS procurement and efficiency board Lord Carter has said the UK health body could save billions …

Draft guidance issued by NICE has seen rejections for products including Celgene’s Otelza and Astellas Pharma’s Xtandi, and a call …

The Department of Health and the ABPI have confirmed a payment of £207 million from pharma to underwrite growth of …

Around 15 million people in England now have at least one long-term condition, but figures suggest that as many as …

The UK healthcare watchdog NICE is to set up a new office for market access to advise pharma companies on …